scholarly journals Myelodysplastic Syndrome Patients with Disease Progression after Cytoreductive Therapy Have Poor Survival and High Non-Relapse Mortality after Full-Intensity Allogeneic Hematopoietic Cell Transplantation

2014 ◽  
Vol 20 (2) ◽  
pp. S223
Author(s):  
Aaron T. Gerds ◽  
Lisa Rybicki ◽  
Betty Ky Hamilton ◽  
Ronald Sobecks ◽  
Hien Duong ◽  
...  
Keyword(s):  
Myelodysplastic Syndrome ◽  
Disease Progression ◽  
Cell Transplantation ◽  
Hematopoietic Cell Transplantation ◽  
Hematopoietic Cell ◽  
Allogeneic Hematopoietic Cell Transplantation ◽  
Poor Survival ◽  
Full Intensity

scholarly journals Multiple donor-derived leukemias in a recipient of allogeneic hematopoietic cell transplantation for myeloid malignancy

2020 ◽  
Vol 4 (19) ◽  
pp. 4798-4801
Author(s):  
Ibrahim Aldoss ◽  
Joo Y. Song ◽  
Peter T. Curtin ◽  
Stephen J. Forman
Keyword(s):  
Transplant Recipient ◽  
Myelodysplastic Syndrome ◽  
Cell Transplantation ◽  
Malignant Transformation ◽  
Hematopoietic Cell Transplantation ◽  
Hematopoietic Cell ◽  
Allogeneic Hematopoietic Cell Transplantation ◽  
Myeloid Malignancy ◽  
Key Points

Key Points A patient with myelodysplastic syndrome was transplanted twice and developed clonally unrelated relapse each time in donor-derived cells. This case supports the concept that a leukemogenic marrow environment may predispose the transplant recipient to malignant transformation.

Sign in / Sign up

Export Citation Format

Share Document